UPDATED
Catalent continues expansion spree with BMS manufacturing facility
Catalent to purchase BMS’s Italian manufacturing facility to gain access to fill/finish capabilities, following several large-scale deals this year.
UPDATED
Catalent to purchase BMS’s Italian manufacturing facility to gain access to fill/finish capabilities, following several large-scale deals this year.
Amgen’s biosimilars portfolio reaches a milestone after its Herceptin biosimilar, Kanjinti, developed in collaboration with Allergan, was approved by the US FDA.
Discovery Labs redevelops former GSK facility in King of Prussia, Pennsylvania, into a coworking area available for leasing by healthcare companies.